TABLE 3

Kinetic parameters (mean ± S.D.) for the formation of 4-hydroxybupropion from bupropion in 15 human liver microsomal samples with CYP2B6*1/*1, CYP2B6*1/*6, and CYP2B6*6/*6 genotypes (n = 5 HLMs for each genotype)

Bupropion (10–1000 μM) were incubated with HLM samples (0.25 mg/ml) with CYP2B6*1/*1, CYP2B6*1/*6, and CYP2B6*6/*6 genotypes (n = 5 HLMs for each genotype) and a NADPH-generating system at 37°C for 15 min in duplicate. Kinetic parameters (Vmax and Km) for the formation of 4-hydroxybupropion were estimated by fitting the velocity versus bupropion concentrations to the simple single-site Michaelis-Menten. In vitro Clint was calculated as Vmax/Km. The kinetic parameters (Vmax, Km, and Clint) for each genotype group are listed in Supplemental Table 2. The data presented here are mean ± S.D. calculated from five individual HLM values for each genotype.

HLMs4-Hydroxybupropion
VmaxKmClint
pmol · min1 · mg protein1μMμl · min1 · mg protein1
CYP2B6*1/*1492.8 ± 427.986.0 ± 75.718.8 ± 26.3
CYP2B6*1/*6441.6 ± 583.0212.1 ± 221.121.8 ± 44.2
CYP2B6*6/*6112.9 ± 66.7204.2 ± 66.10.6 ± 0.5